Myriad Genetics, Inc. · NASDAQ:MYGN
State Street Corp's stake in Myriad Genetics, Inc. fell to 4.70% (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp's stake in Myriad Genetics, Inc. fell to 4.70%, 4,424,027 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 4.70%
- Shares
- 4,424,027
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.70% | 4,424,027 |
Source
Related
- Myriad Genetics, Inc.
- State Street Corp
- Myriad Genetics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · Feb 9, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026